EXHIBIT 10.5
                                                                    ------------

                                                                   JUNE 12, 2008

                       SECURED CONVERTIBLE PROMISSORY NOTE

THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to iVoice, Inc.,
all of the Fees as defined in Section 3 of Administrative Services Agreement by
and between Thomas Pharmaceuticals, Ltd. (the "Company") and iVoice, Inc. dated
March 1, 2007, as amended, that have been earned, accrued and remain unpaid and
have been converted into this Secured Convertible Promissory Note at the rate of
Prime plus 1 percent per annum on the unpaid balance until paid or until
default, both principal and interest payable in lawful money of the United
States of America, at iVoice, Inc. (the "iVoice") 750 Highway 34, Matawan, New
Jersey 07747, or at such place as the legal holder hereof may designate in
writing. It is understood and agreed that additional amounts may be advanced by
the holder hereof as provided in the instruments, if any, securing this Secured
Convertible Promissory Note and such advances will be added to the principal of
this Secured Convertible Promissory Note and will accrue interest at the above
specified rate of interest from the date of advance until paid. The principal
and interest shall be due and payable as follows: (a) interest shall accrue
monthly on the unpaid balance and shall be paid annually, and (b) principal
shall be payable on demand.

1.   Notwithstanding anything to the contrary herein, the Secured Convertible
     Promissory Note holder may elect payment of the principal and/or interest,
     at the holder's sole discretion, owed pursuant to this Note by the Company
     to issue to iVoice, or his assigns either: (i) one Class B common stock
     share of Thomas Pharmaceuticals no par value per share, for each dollar
     owed, (ii) the number of Class A common stock shares of Thomas
     Pharmaceuticals calculated by dividing (x) the sum of the principal and
     interest that the Note holder has decided to have paid by (y) eighty
     percent (80%) of the lowest trading price of Thomas Pharmaceuticals Class A
     common stock in the previous thirty (30) trading days, or (iii), payment of
     the principal of this Secured Convertible Promissory Note, before any
     repayment of interest. For purposes of determining the holding period of
     this Secured Convertible Promissory Note under Rule 144 of the regulations
     promulgated by the Securities and Exchange Commission under the Securities
     Act of 1933, as amended, Exhibit I attached herein shows the date that each
     monthly obligation pursuant to the Agreement became due and unpaid. This
     Exhibit I shall be amended from time to time to reflect additional monthly
     advances made pursuant to the Agreement referenced above. Notwithstanding
     anything to the contrary, The Company shall not issue iVoice either Class A
     and/or Class B Common Stock as required in the paragraph should the total
     aggregate beneficial holdings of Thomas Pharmaceuticals Class A Common
     Stock by iVoice exceeds 9.99% of the total outstanding Class A Common Stock
     at the time of conversion of the monies owed under this Secured Convertible
     Promissory Note.


<PAGE>
2.   Unless otherwise provided, this Secured Convertible Promissory Note may be
     prepaid in full or in part at any time without penalty or premium. Partial
     prepayments shall be applied to installments due in reverse order of their
     maturity.

3.   In the event of (a) default in payment of any installment of principal or
     interest hereof as the same becomes due and such default is not cured
     within ten (10) days from the due date, or (b) default under the terms of
     any instrument securing this Secured Convertible Promissory Note, and such
     default is not cured within fifteen (15) days after written notice to
     maker, then in either such event the holder may, without further notice,
     declare the remainder of the principal sum, together with all interest
     accrued thereon, and the prepayment premium, if any, at once due and
     payable. Failure to exercise this option shall not constitute a waiver of
     the right to exercise the same at any other time. The unpaid principal of
     this Secured Convertible Promissory Note and any part thereof, accrued
     interest and all other sums due under this Secured Convertible Promissory
     Note shall bear interest at the rate of prime plus 2 percent per annum
     after default until paid.

4.   All parties to this Secured Convertible Promissory Note, including maker
     and any sureties, endorsers, or guarantors, hereby waive protest,
     presentment, notice of dishonor, and notice of acceleration of maturity and
     agree to continue to remain bound for the payment of principal, interest,
     and all other sums due under this Secured Convertible Promissory Note,
     notwithstanding any change or changes by way of release, surrender,
     exchange, modification or substitution of any security for this Secured
     Convertible Promissory Note or by way of any extension or extensions of
     time for the payment of principal and interest; and all such parties waive
     all and every kind of notice of such change or changes and agree that the
     same may be made without notice or consent of any of them.

5.   Upon default, the holder of this Secured Convertible Promissory Note may
     employ an attorney to enforce the holder's rights and remedies and the
     maker, principal, surety, guarantor and endorsers of this Secured
     Convertible Promissory Note hereby agree to pay to the holder reasonable
     attorneys fees, plus all other reasonable expenses incurred by the holder
     in exercising any of the holder's right and remedies upon default. The
     failure to exercise any such right or remedy shall not be a waiver or
     release of such rights or remedies or the right to exercise any of them at
     another time.

6.   This Secured Convertible Promissory Note is to be governed and construed in
     accordance with the laws of the State of New Jersey.

7.   The monies owed under this Secured Convertible Promissory Note shall be
     secured by a security interest as set forth in a Security Agreement dated
     the date hereof.
<PAGE>
IN TESTIMONY WHEREOF, each corporate maker has caused this instrument to be
executed in its corporate name by its President, and its corporate seal to be
hereto affixed, all by order of its Board of Directors first duly given, the day
and year first written above:






THOMAS PHARMACEUTICALS, LTD.



By: ___________________________
    Mark Meller
    President and
    Chief Executive Officer